ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
ACAD
36.73
-0.26
-0.70%
AEMD
0.98
+0.01
+1.03%
APRI
1.9
+0.11
+6.15%
ARNA
27.56
+0.71
+2.64%
ATEC
4.13
+0.36
+9.55%
CNAT
5.15
+0.05
+0.98%
CRXM
0.137
-0.018
-11.71613%
CYTX
0.486
+0.016
+3.470%
DXCM
44.95
-0.04
-0.09%
GNMK
8.06
-0.05
-0.62%
HALO
17.72
-0.02
-0.11%
ILMN
205.62
-0.86
-0.42%
INNV
0.09
+0.003
+3.6994%
INO
6.32
+0.08
+1.28%
ISCO
1.51
-0.16
-9.58%
ISIS
57.56
0.00
0.00%
LGND
144.16
+2.01
+1.41%
LPTN
2.93
-2.93
-100.00%
MBVX
0.715
-0.015
-2.082%
MEIP
2.48
+0.15
+6.44%
MNOV
6.38
-0.24
-3.63%
MRTX
14.35
+0.1
+0.70%
MSTX
0.13
-0.01
0.00%
NBIX
59.42
-1.45
-2.38%
NUVA
54.18
+0.47
+0.88%
ONCS
1.28
+0.07
+5.79%
ONVO
1.48
-0.04
-2.63%
OREX
1.87
-0.02
-1.06%
OTIC
3.45
-0.02
-0.72%
QDEL
41.71
+0.35
+0.85%
RCPT
231.96
0.00
0.00%
RGLS
1.32
0.00
0.00%
RMD
78.87
+0.45
+0.57%
SCIE
0
0.00
0.00%
SPHS
2.243
-0.037
-1.6272%
SRNE
2.6
-0.25
-8.77%
TROV
0.868
+0.078
+9.873%
VICL
2.38
-0.15
-5.93%
VOLC
18
0.00
0.00%
ZGNX
39
+0.9
+2.36%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.

Be Sociable, Share!